Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Cancers
|
November 27, 2019
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Audrey Bellesoeur, Edouard Ollier, Marie Allard, et al.
Therapeutic Advances in Medical Oncology
|
March 8, 2024
Resected <i>EGFR</i>-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study)
Jean-Bernard Auliac, Pascal-Alexandre Thomas, Olivier Bylicki, et al.
Cancer Research
|
December 25, 2013
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells
Jérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2015
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Nicolas A Giraldo, Etienne Becht, Franck Pagès, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2013
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin
Romain Remark, Marco Alifano, Isabelle Cremer, et al.
Journal for Immunotherapy of Cancer
|
October 17, 2020
Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
Jules Russick, Pierre-Emmanuel Joubert, Mélanie Gillard-Bocquet, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Cancers
|
November 27, 2019
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Audrey Bellesoeur, Edouard Ollier, Marie Allard, et al.
Therapeutic Advances in Medical Oncology
|
March 8, 2024
Resected <i>EGFR</i>-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study)
Jean-Bernard Auliac, Pascal-Alexandre Thomas, Olivier Bylicki, et al.
Cancer Research
|
December 25, 2013
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells
Jérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2015
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Nicolas A Giraldo, Etienne Becht, Franck Pagès, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2013
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin
Romain Remark, Marco Alifano, Isabelle Cremer, et al.
Journal for Immunotherapy of Cancer
|
October 17, 2020
Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
Jules Russick, Pierre-Emmanuel Joubert, Mélanie Gillard-Bocquet, et al.
Page
of 5